- Home
- ESSA vs MOLN Comparison
ESSA vs MOLN Comparison
Compare ESSA & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESSA
- MOLN
- Stock Information
- Founded
- ESSA 1916
- MOLN 2004
- Country
- ESSA United States
- MOLN Switzerland
- Employees
- ESSA N/A
- MOLN N/A
- Industry
- ESSA Banks
- MOLN
- Sector
- ESSA Finance
- MOLN
- Exchange
- ESSA Nasdaq
- MOLN Nasdaq
- Market Cap
- ESSA 206.9M
- MOLN 195.4M
- IPO Year
- ESSA N/A
- MOLN 2021
- Fundamental
- Price
- ESSA $19.50
- MOLN $5.19
- Analyst Decision
- ESSA
- MOLN
- Analyst Count
- ESSA 0
- MOLN 0
- Target Price
- ESSA N/A
- MOLN N/A
- AVG Volume (30 Days)
- ESSA 13.4K
- MOLN 25.4K
- Earning Date
- ESSA 01-22-2025
- MOLN 08-26-2024
- Dividend Yield
- ESSA 3.08%
- MOLN N/A
- EPS Growth
- ESSA N/A
- MOLN N/A
- EPS
- ESSA 1.78
- MOLN N/A
- Revenue
- ESSA $67,843,000.00
- MOLN $7,105,397.00
- Revenue This Year
- ESSA N/A
- MOLN N/A
- Revenue Next Year
- ESSA N/A
- MOLN $29.41
- P/E Ratio
- ESSA $10.96
- MOLN N/A
- Revenue Growth
- ESSA N/A
- MOLN N/A
- 52 Week Low
- ESSA $15.29
- MOLN $3.32
- 52 Week High
- ESSA $21.50
- MOLN $12.70
- Technical
- Relative Strength Index (RSI)
- ESSA 43.34
- MOLN 42.35
- Support Level
- ESSA $19.58
- MOLN $5.25
- Resistance Level
- ESSA $20.30
- MOLN $5.46
- Average True Range (ATR)
- ESSA 0.54
- MOLN 0.21
- MACD
- ESSA -0.15
- MOLN -0.04
- Stochastic Oscillator
- ESSA 23.53
- MOLN 6.67
About ESSA ESSA Bancorp Inc.
ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.